...

首页> 外文期刊>Cancer Management and Research >Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

【24h】

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

机译：绝经后妇女患有内分泌抵抗，激素受体阳性，人类表皮生长因子受体2阴性的晚期乳腺癌对社区肿瘤学家的治疗挑战

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer Management and Research》 |2016年第4期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类一般性问题;
关键词

相似文献

外文文献
中文文献
专利

1. Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer [J] . William J Gradishar Cancer Management and Research . 2016,第1期

机译：绝经后妇女患有内分泌抵抗，激素受体阳性，人类表皮生长因子受体2阴性的晚期乳腺癌对社区肿瘤学家的治疗挑战
2. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib plus letrozole: results from MONALEESA-2 [J] . Verma Sunil, OShaughnessy Joyce, Burris Howard A., Breast cancer research and treatment. . 2018,第3期

机译：与激素受体阳性，人体表皮生长因子受体2阴性晚期乳腺癌的卫生症患者患者的卫生症患者的妇女生活质量阳性，用核发生杆菌加仑唑唑：Monaleesa-2的结果
3. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib plus letrozole: results from MONALEESA-2 [J] . Verma Sunil, OShaughnessy Joyce, Burris Howard A., Breast cancer research and treatment. . 2018,第3期

机译：与激素受体阳性，人体表皮生长因子受体2阴性晚期乳腺癌治疗的健康相关性生活质量，用核心杆菌加仑唑唑治疗：Monaleesa-2的结果
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer [O] . William J Gradishar 2016

机译：绝经后妇女患有内分泌抵抗激素受体阳性人表皮生长因子受体2阴性的晚期乳腺癌的社区肿瘤学家的治疗挑战
7. Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer [O] . Hikmat Abdel-Razeq 2016

机译：患有内分泌抗性，激素受体阳性，人表皮生长因子受体2阴性晚期乳腺癌治疗绝经后妇女治疗绝经后妇女的攻击挑战
8. Immunotherapeutic Approach to the Treatment and Prevention of Breast Cancer, Based on Epidermal Growth Factor Receptor Variant, Type III [R] . Gilliam, L. K. , Hale, L. 1999

机译：基于表皮生长因子受体变体III型的免疫治疗方法治疗和预防乳腺癌

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号